Omega Alpha SPAC focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. The company was founded in 2004 and is headquartered in Boston, Massachusetts.
IPO Year: 2021
Exchange: NASDAQ
Fastest customizable press release news feed in the world
BOSTON, Dec. 17, 2021 /PRNewswire/ -- Omega Funds, a leading international healthcare venture capital firm focused on delivering impactful medicines to patients, today announced it has closed its seventh and largest fund with $650 million in limited partner capital commitments. The new fund, Omega Fund VII, L.P. ("Fund VII"), was oversubscribed, exceeding the firm's targeted raise of $500 million, and included strong support from both new and existing limited partners. With Fund VII, the firm will continue to execute on its strategy of creating and investing in life sciences companies in the US and Europe that target severe, unmet medical needs. Since its inception in 2004, Omega Funds has r
15-12G - Omega Alpha SPAC (0001832010) (Filer)
25-NSE - Omega Alpha SPAC (0001832010) (Subject)
8-K - Omega Alpha SPAC (0001832010) (Filer)
10-Q - Omega Alpha SPAC (0001832010) (Filer)
10-Q/A - Omega Alpha SPAC (0001832010) (Filer)
10-Q/A - Omega Alpha SPAC (0001832010) (Filer)
10-Q - Omega Alpha SPAC (0001832010) (Filer)
10-Q - Omega Alpha SPAC (0001832010) (Filer)
10-Q/A - Omega Alpha SPAC (0001832010) (Filer)
8-K - Omega Alpha SPAC (0001832010) (Filer)
This live feed shows all institutional transactions in real time.
SC 13G/A - Omega Alpha SPAC (0001832010) (Subject)
SC 13G/A - Omega Alpha SPAC (0001832010) (Subject)
SC 13G/A - Omega Alpha SPAC (0001832010) (Subject)
SC 13G/A - Omega Alpha SPAC (0001832010) (Subject)
SC 13G - Omega Alpha SPAC (0001832010) (Subject)
SC 13G - Omega Alpha SPAC (0001832010) (Subject)
SC 13G/A - Omega Alpha SPAC (0001832010) (Subject)
SC 13G/A - Omega Alpha SPAC (0001832010) (Subject)
SC 13G - Omega Alpha SPAC (0001832010) (Subject)